Related references
Note: Only part of the references are listed.The future of cystic fibrosis care: a global perspective
Scott C. Bell et al.
LANCET RESPIRATORY MEDICINE (2020)
Utilisation, expenditure and cost-effectiveness of cystic fibrosis drugs in Ireland: a retrospective analysis of a national pharmacy claims database
Amelia Smith et al.
BMJ OPEN (2020)
Approach to record linkage of primary care data from Clinical Practice Research Datalink to other health-related patient data: overview and implications
Shivani Padmanabhan et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2019)
The Economic Burden of Cystic Fibrosis in Germany from a Payer Perspective
Simon Frey et al.
PHARMACOECONOMICS (2019)
GUILD: GUidance for Information about Linking Data sets
Ruth Gilbert et al.
JOURNAL OF PUBLIC HEALTH (2018)
ECFS best practice guidelines: the 2018 revision
Carlo Castellani et al.
JOURNAL OF CYSTIC FIBROSIS (2018)
Healthcare expenditures for privately insured US patients with cystic fibrosis, 2010-2016
Scott D. Grosse et al.
PEDIATRIC PULMONOLOGY (2018)
Socioeconomic Inequalities in the Kidney Transplantation Process: A Registry-Based Study in Sweden
Ye Zhang et al.
TRANSPLANTATION DIRECT (2018)
The burden of cystic fibrosis in the Medicaid population
Mariam Hassan et al.
CLINICOECONOMICS AND OUTCOMES RESEARCH (2018)
Costs of treatment of adult patients with cystic fibrosis in Poland and internationally
Dorota Kopciuch et al.
PUBLIC HEALTH (2017)
Value of a national administrative database to guide public decisions: From the systeme national d'information interregimes de l'Assurance Maladie (SNIIRAM) to the systeme national des donnees de sante (SNDS) in France
P. Tuppin et al.
REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE (2017)
Efficacy and safety of lumacaftor/ivacaftor combination therapy in patients with cystic fibrosis homozygous for Phe508del CFTR by pulmonary function subgroup: a pooled analysis
J. Stuart Elborn et al.
LANCET RESPIRATORY MEDICINE (2016)
Social/economic costs and health-related quality of life in patients with cystic fibrosis in Europe
Karine Chevreul et al.
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2016)
Accuracy and completeness of patient pathways - the benefits of national data linkage in Australia
James H. Boyd et al.
BMC HEALTH SERVICES RESEARCH (2015)
Social and economic costs and health-related quality of life in non-institutionalised patients with cystic fibrosis in the United Kingdom
Aris Angelis et al.
BMC HEALTH SERVICES RESEARCH (2015)
Costs and health-related quality of life of patients with cystic fibrosis and their carers in France
Karine Chevreul et al.
JOURNAL OF CYSTIC FIBROSIS (2015)
Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR
C. E. Wainwright et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
European Cystic Fibrosis Society Standards of Care: Best Practice guidelines
Alan R. Smyth et al.
JOURNAL OF CYSTIC FIBROSIS (2014)
Quality of life and healthcare utilisation in cystic fibrosis: a multicentre study
Judy M. Bradley et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
Cost of Illness of Cystic Fibrosis in Germany Results from a Large Cystic Fibrosis Centre
Mareike Heimeshoff et al.
PHARMACOECONOMICS (2012)
Record linkage for pharmacoepidemiological studies in cancer patients
Myrthe P. P. van Herk-Sukel et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2012)
A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation
Bonnie W. Ramsey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
High treatment burden in adults with cystic fibrosis: Challenges to disease self-management
Gregory S. Sawicki et al.
JOURNAL OF CYSTIC FIBROSIS (2009)
Evolution of costs of care for cystic fibrosis patients after clinical guidelines implementation in a French network
Laure Huot et al.
JOURNAL OF CYSTIC FIBROSIS (2008)
Cost of home and hospital care for patients with cystic fibrosis followed up in two reference medical centers in France
Valrie Horvais et al.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2006)
Share Paper
